The anti-inflammatory actions of LCY-2-CHO, a carbazole analogue, in vascular smooth muscle cells

Biochemical Pharmacology

Volumn 74, Issue 2, 2007, Pages 298-308

  Ho, Feng Ming ^a,b   Kang, Hao Cheng ^c   Lee, Sho Tone ^d   Chao, Yee ^e   Chen, You Ci ^c   Huang, Li Jiau ^f   Lin, Wan Wan ^c  

^a TAO YUAN GENERAL HOSPITAL   (Taiwan)

^b CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Anti inflammation; Cell signaling; HO 1; LCY 2 CHO; Vascular smooth muscle

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 9 (2 CHLOROBENZYL) 9H CARBAZOLE 3 CARBALDEHYDE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CARBAZOLE DERIVATIVE; CYCLOOXYGENASE 2; HEME OXYGENASE 1; I KAPPA B ALPHA; I KAPPA B KINASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; GENE EXPRESSION; GENE INDUCTION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; VASCULAR SMOOTH MUSCLE;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CARBAZOLES; CELL SURVIVAL; CELLS, CULTURED; CHEMOKINES, CXC; GENE EXPRESSION REGULATION; HEME OXYGENASE (DECYCLIZING); INTERLEUKIN-1BETA; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-E2-RELATED FACTOR 2; NITRIC OXIDE SYNTHASE TYPE II; RATS; SIGNAL TRANSDUCTION;

EID: 34249983852     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2007.04.008     Document Type: Article

References (46)

1. Ryter S.W., Otterbein L.E., Morse D., and Choi A.M. Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Mol Cell Biochem 234-235 (2002) 249-263
2. Maines M.D., Trakshel G.M., and Kutty R.K. Characterization of two constitutive forms of rat liver microsomal heme oxygenase. Only one molecular species of the enzyme is inducible. J Biol Chem 261 (1986) 411-419
3. Maines M.D. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J 2 (1988) 2557-2568
4. McCoubrey Jr. W.K., Huang T.J., and Maines M.D. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem 247 (1997) 725-732
5. Hayashi S., Omata Y., Sakamoto H., Higashimoto Y., Hara T., Sagara Y., et al. Characterization of rat heme oxygenase-3 gene. Implication of processed pseudogenes derived from heme oxygenase-2 gene. Gene 336 (2004) 241-250
6. Durante W., Kroll M.H., Christodoulides N., Peyton K.J., and Schafer A.I. Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ Res 80 (1997) 557-564
7. Tian W., Bonkovsky H.L., Shibahara S., and Cohen D.M. Urea and hypertonicity increase expression of heme oxygenase-1 in murine renal medullary cells. Am J Physiol Renal Physiol 281 (2001) F983-F991
8. Liu X.M., Peyton K.J., Ensenat D., Wang H., Schafer A.I., Alam J., et al. Endoplasmic reticulum stress stimulates heme oxygenase-1 gene expression in vascular smooth muscle. J Biol Chem 280 (2005) 872-877
9. Otterbein L.E., and Choi A.M.K. Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol 279 (2000) L1029-L1037
10. Ishikawa K., and Maruyama Y. Heme oxygenase as an intrinsic defense system in vascular wall: implication against atherogenesis. J Atheroscler Thromb 8 (2001) 63-70
11. Juan S.H., Lee T.S., Tseng K.W., Liou J.Y., Shyue S.K., Wu K.K., et al. Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 104 (2001) 1519-1525
12. Durante W. Heme oxygenase-1 in growth control and its clinical application to vascular disease. J Cell Physiol 195 (2003) 373-382
13. Yet S.F., Layne M.D., Liu X., Chen Y.H., Ith B., Sibinga N.E., et al. Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodelling. FASEB J 17 (2003) 1759-1761
14. Immenschuh S., and Ramadori G. Gene regulation of heme oxygenase-1 as a therapeutic target. Biochem Pharmacol 60 (2000) 1121-1128
15. Zhang X., Bedard E.L., Potter R., Zhong R., Alam J., Choi A.M., et al. Mitogen-activated protein kinases regulate HO-1 gene transcription after ischemia-reperfusion lung injury. Am J Physiol Lung Cell Mol Physiol 283 (2002) L815-L819
16. Martin D., Rojo A.I., Salinas M., Diaz R., Gallardo G., Alam J., et al. Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. J Biol Chem 279 (2004) 8919-8929
17. Gong P., Stewart D., Hu B., Vinson C., and Alam J. Multiple basic-leucine zipper proteins regulate induction of the mouse heme oxygenase-1 gene by arsenite. Arch Biochem Biophys 405 (2002) 265-274
18. Alam J., Wicks C., Steward D., Gong P., Touchard C., Otterbein S., et al. Mechanisms of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells. Role of p38 kinase and Nrf2 transcription factor. J Biol Chem 275 (2000) 27694-27702
19. 2 is mediated by the stress response elements and transcription factor Nrf2. Antioxid Redox Signal 4 (2002) 249-257
20. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J.D., et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 13 (1999) 76-86
21. Balogun E., Hoque M., Gong P., Killeen E., Green C.J., Foresti R., et al. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J 371 (2003) 887-895
22. Numazawa S., and Yoshida T. Nrf2-dependent gene expressions: a molecular toxicological aspect. J Toxicol Sci 29 (2004) 81-89
23. Wu C.C., Hsieh C.W., Lai P.H., Lin J.B., Liu Y.C., and Wung B.S. Upregulation of endothelial heme oxygenase-1 expression through the activation of the JNK pathway by sublethal concentrations of acrolein. Toxicol Appl Pharmacol 214 (2006) 244-252
24. Wu C.C., Hsu M.C., Hsieh C.W., Lin J.B., Lai P.H., and Wung B.S. Upregulation of heme oxygenase-1 by Epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathways. Life Sci 78 (2006) 2889-2897
25. Lee C.Y., Huang L.J., Wang J.P., and Kuo S.C. Anti-inflammatory activity of 9-substituted benzyl-3-substituted carbazole derivatives. Chin Pharm J 54 (2002) 35-40
26. Lee C.Y., Kuo S.C., Teng C.M., and Huang L.J. Synthesis and antiplatelet activity of 9-benzyl-3-hydroxymethylcarbazoles. Chin Pharm J 54 (2002) 25-34
27. Tsao L.T., Lee C.Y., Huang L.J., Kuo S.C., and Wang J.P. Inhibition of lipopolysaccharide-stimulated nitric oxide production in RAW 264.7 macrophages by a synthetic carbazole, LCY-2-CHO. Biochem Pharmacol 63 (2002) 1961-1968
28. Ho F.M., Lai C.C., Huang L.J., Kuo T.C., Chao C.M., and Lin W.W. The anti-inflammatory carbazole, LCY-2-CHO, inhibits lipopolysaccharide-induced inflammatory mediator expression through inhibition of the p38 mitogen-activated protein kinase signaling pathway in macrophages. Br J Pharmacol 141 (2004) 1037-1047
29. Boo Y.C., and Jo H. Flow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases. Am J Physiol Cell Physiol 285 (2003) C499-C508
30. Hara E., Takahashi K., Takeda K., Nakayama M., Yoshizawa M., Fujita H., et al. Induction of heme oxygenase-1 as a response in sensing the signals evoked by distinct nitric oxide donors. Biochem Pharmacol 58 (1999) 227-236
31. Motterlini R., Foresti R., Bassi R., Calabrese V., Clark J.E., and Green C.J. Endothelial heme oxygenase-1 induction by hypoxia. Modulation by inducible nitric-oxide synthase and S-nitrosothiols. J Biol Chem 275 (2000) 13613-13620
32. Buckley B.J., Marshall Z.M., and Whorton A.R. Nitric oxide stimulates Nrf2 nuclear translocation in vascular endothelium. Biochem Biophys Res Commun 307 (2003) 973-979
33. Park E.Y., and Kim S.G. NO signaling in ARE-mediated gene expression. Methods Enzymol 396 (2005) 341-349
34. Behr D., Rupin A., Fabiani J.N., and Verbeuren T.J. Distribution and prevalence of inducible nitric oxide synthase in atherosclerotic vessels of long-term cholesterol-fed rabbits. Atherosclerosis 142 (1999) 335-344
35. 2-dependent plaque instability. Circulation 104 (2001) 921-927
36. Hansson G.K. Immune mechanisms in atherosclerosis. Atheroscler Thromb Vasc Biol 21 (2001) 1876-1890
37. Boisvert W.A., Rose D.M., Johnson K.A., Fuentes M.E., Lira S.A., Curtiss L.K., et al. Up-regulated expression of the CXCR2 ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. Am J Pathol 168 (2006) 1385-1395
38. Luoma J.S., and Ylä-Herttuala S. Expression of inducible nitric oxide synthase in macrophages and smooth muscle cells in various types of human atherosclerotic lesions. Virchows Arch 434 (1999) 561-568
39. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol 18 (2000) 621-663
40. Issa R., Xie S., Lee K.Y., Stanbridge R.D., Bhavsar P., Sukkar M.B., et al. GRO-alpha regulation in airway smooth muscle by IL-1beta and TNF-alpha: role of NF-kappaB and MAP kinases. Am J Physiol Lung Cell Mol Physiol 291 (2006) L66-L74
41. Cho H.Y., Reddy S.P., and Kleeberger S.R. Nrf2 defends the lung from oxidative stress. Antioxid Redox Signal 8 (2006) 76-87
42. Hosoya T., Maruyama A., Kang M.I., Kawatani Y., Shibata T., Uchida K., et al. Differential responses of the Nrf2-Keap1 system to laminar and oscillatory shear stresses in endothelial cells. J Biol Chem 280 (2005) 27244-27250
43. Chen X.L., Dodd G., Thomas S., Zhang X., Wasserman M.A., Rovin B.H., et al. Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. Am J Physiol Heart Circ Physiol 290 (2006) H1862-H1870
44. Sherratt P.J., McLellan L.I., and Hayes J.D. Positive and negative regulation of prostaglandin E2 biosynthesis in human colorectal carcinoma cells by cancer chemopreventive agents. Biochem Pharmacol 66 (2003) 51-61
45. Zhang X., Chen X., Song H., Chen H.Z., and Rovin B.H. Activation of the Nrf2/antioxidant response pathway increases IL-8 expression. Eur J Immunol 35 (2005) 3258-3267
46. Yang H., Magilnick N., Lee C., Kalmaz D., Ou X., Chan J.Y., et al. Nrf1 and Nrf2 regulate rat glutamate-cysteine ligase catalytic subunit transcription indirectly via NF-kappaB and AP-1. Mol Cell Biol 25 (2005) 5933-5946